Leuprolide Completed Phase 1 Trials for Prostate Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00026377SU5416 Plus Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
NCT00943956Everolimus, Bicalutamide, and Leuprolide Acetate in Treating Patients Undergoing Radiation Therapy For High-Risk Locally Advanced Prostate Cancer
NCT00631527Sunitinib Malate, Hormone Ablation and Radiation Therapy in Patients With Prostate Cancer